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Introduction
Acid–base balance is regulated both at the cellular and whole
organism levels. Specialized systems for the elimination of
CO2/HCO3– and other H+ equivalents control systemic pH. At the
cellular and subcellular levels, homeostasis is maintained by a fine
balance between net acid generation and extrusion. In mammalian
cells, H+ (equivalents) generated metabolically are extruded by two
main pathways: (1) through the efflux of organic acids (e.g. lactate)
via H+ symporters, and (2) in exchange for extracellular Na+ by an
antiport mechanism. The entities responsible for the latter process
are known as Na+/H+ exchangers (NHEs). Na+/H+ exchange
provides a robust, electroneutral pathway for net acid extrusion by
utilizing the energy inherent to the inward Na+ concentration
gradient generated by the sodium/potassium-ATPase (Na+/K+-
ATPase) (Bobulescu and Moe, 2006; Brett et al., 2005; Donowitz
and Li, 2007; Fliegel, 2008; Malo and Fliegel, 2006; Orlowski and
Grinstein, 2007; Slepkov et al., 2007).
In addition to their key role in pH homeostasis, it has recently
become apparent that NHEs serve many other functions: they are
instrumental to Na+ (re)absorption in the renal and gastrointestinal
tracts; they play an important role in cell volume regulation,
particularly in guarding cells against shrinkage; they seem to be
stringently required for macropinocytosis; and they have been
proposed to be involved in cell migration. This functional
versatility stems in part from the evolutionary divergence of a
primordial NHE into multiple isoforms with unique properties and
specialized functions (Brett et al., 2005; Orlowski and Grinstein,
2004).
NHE isoforms
There are nine known NHE isoforms in the mammalian genome
(Brett et al., 2005; Orlowski and Grinstein, 2004). These can be
grossly subdivided into two groups: those that reside and function
predominantly in the plasma membrane (NHE1–5) and those that
are found largely or exclusively in endomembrane organelles
(NHE6–9). The latter can in turn be subdivided into two separate
phylogenetic clades: NHE6, 7 and 9, which are related to the yeast
NHX1 (sodium–proton exchanger; non-mammalian) and reside in
the endosomal/TGN (trans-Golgi network) pathway; and NHE8 that
has orthologues in Dictyostelium, worms and flies, and in mammals
is found both in endomembranes and on the apical membrane of
certain epithelia (Brett et al., 2005; Orlowski and Grinstein, 2004;
Slepkov et al., 2007). In addition, a distinct type of NHEs related to
the bacterial NhaA and yeast NHA1 (sodium–proton antiporter) was
recently identified also in the mammalian genome (Brett et al., 2005;
Xiang et al., 2007). Like the transporters of lower organisms, the
mammalian paralogues NHA1 and NHA2 are likely to be
electrogenic (see below) and may have unique functions, although
remarkably little is known about them at present.
The plasmalemmal NHEs have varied tissue distribution and
function. Some, like the ubiquitously expressed NHE1, are
restricted to the plasma membrane and serve housekeeping
functions such as pH homeostasis and cell volume regulation
(Bobulescu and Moe, 2006; Fliegel, 2008; Orlowski and
Grinstein, 2007; Slepkov et al., 2007). Others, like the apical
epithelial isoform NHE3, can cycle between the surface
membrane and intracellular compartments and have highly
specialized functions including trans-epithelial Na+ transport and
systemic acid–base homeostasis (Bobulescu and Moe, 2006;
Donowitz and Li, 2007). The unique tissue distribution of NHE3
(detailed below) implicates it in critical physiological processes
like the control of systemic volume and pH. In addition, its
specific subcellular localization confers complexity to its
regulation, facilitating dynamic alterations in function. Because
of its distinguishing features and its functional importance we
have chosen to make NHE3 the focus of this review.
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Summary
NHE3 is a sodium–proton exchanger expressed predominantly in the apical membrane of renal and intestinal epithelia, where it
plays a key role in salt and fluid absorption and pH homeostasis. It performs these functions through the exchange of luminal
sodium for cytosolic protons. Acute regulation of NHE3 function is mediated by altering the total number of exchangers in the
plasma membrane as well as their individual activity. Traffic between endomembrane and plasmalemmal pools of NHE3 dictates
the density of exchangers available at the cell surface. The activity of the plasmalemmal pool, however, is not fixed and can be
altered by the association with modifier proteins, by post-translational alterations (such as cAMP-mediated phosphorylation) and
possibly also via interaction with specific plasmalemmal phospholipids. Interestingly, association with cytoskeletal components
affects both levels of regulation, tethering NHE3 molecules at the surface and altering their intrinsic activity. This paper reviews
the role of proteins and lipids in the modulation of NHE3 function.
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Tissue distribution
NHE3 is found almost exclusively in the epithelia of renal and
gastrointestinal tissue (Brant et al., 1995; Orlowski et al., 1992; Tse
et al., 1992), although there is some suggestion that a low level of
expression also occurs in human thymus, prostate, testis and ovary
(Brant et al., 1995). Renal expression of NHE3 occurs in distinct
segments of the nephron and is exclusive to the luminal side of
tubular epithelial cells (Bobulescu et al., 2005a). Specifically,
NHE3 is located in the proximal tubule and the thick descending
limb of the loop of Henle (Biemesderfer et al., 1997). Within the
gastrointestinal tract, NHE3 is more widely distributed. It can be
found in epithelia from stomach, small intestine and large intestine.
It is found throughout all segments of the colon but its expression
is limited to the jejunum of the small intestine and the corpus and
antrum of the stomach (Orlowski et al., 1992; Tse et al., 1992).
NHE3 structure
NHE3 shares with the other NHE isoforms a bipartite structure: an
N-terminal, 12 pass transmembrane domain (residues 1–454 in the
case of NHE3), followed by a relatively unstructured cytosolic C-
terminal domain (residues 455–831) (Fig.1). The transmembrane
domain mediates ion exchange while the cytosolic C-terminus
regulates activity and interacts with the cytoskeleton and other
ancillary molecules. In contrast to most other isoforms, significant
empirical evidence exists to support this structure. The addition of
epitopes to NHE3 confirmed that the first loop, linking
transmembrane helices 1 and 2, is extracellular (Kurashima et al.,
1998). A similar approach confirmed that the cytosolic C-terminus
is intracellular (Kurashima et al., 1998). Although this proposed
structure for NHE3 is widely accepted (Donowitz et al., 2005;
Orlowski and Grinstein, 2004; Weinman et al., 2005; Zachos et al.,
2005), there is some conflicting evidence suggesting that epitopes
within the cytosolic C-terminus may be exposed to the extracellular
milieu (Biemesderfer et al., 1998), and a single in vitro analysis
suggests that NHE3 may contain a N-terminal signal sequence
which is cleaved, leaving only 11 transmembrane domains (Zizak
et al., 2000).
Mutational analysis of, and comparisons to, NHE1 have
implicated transmembrane (TM) domains IV and VII of NHE3 in
ion transport and TM domain IX as the site of binding to amiloride
analogues (Orlowski and Kandasamy, 1996; Slepkov et al., 2005).
Experiments utilizing chimeric and truncation mutants enabled the
localization of different regulatory domains within the C-terminus.
These include sites responsible for cAMP-mediated inhibition, a
calcineurin homologous protein (CHP)-binding site and regions
responsible for phorbol ester and okadaic acid-mediated inhibition
(Cabado et al., 1996; Levine et al., 1995; Wakabayashi et al., 1995).
Similarly, by mutating specific residues in the C-terminus it was
shown that both ezrin and NHERF-1/2 (sodium–hydrogen
exchanger regulatory factor) bind to this section of NHE3 (Cha et
al., 2006; Weinman et al., 2003b).
In contrast to NHE1 (Counillon et al., 1994), NHE3 is generally
thought not to be glycosylated in most systems (Orlowski and
Grinstein, 2004). Rabbit renal brush border membranes and porcine
LLCPK cells appear to be exceptions, because experiments
utilizing inhibitors of glycosylation in combination with SDS-
PAGE analysis suggested that, in these systems, NHE3 is
glycosylated. Moreover, in these studies inhibition of glycosylation
prevented the apical expression of NHE3 (Bizal et al., 1996;
Soleimani et al., 1996). Canine, rat, human and opossum NHE3,
which are seemingly not glycosylated, must possess other apical
targeting motifs (Bizal et al., 1996; Durkan et al., 2007). Finally,
as with NHE1 (Fuster et al., 2008; Hisamitsu et al., 2006; Hisamitsu
et al., 2004), the functional unit of NHE3 in the apical plasma
membrane is likely to be a homodimer or possibly a higher order
oligomer (Fafournoux et al., 1994).
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Fig. 1. The structure of NHE3 is divided into 12
transmembrane domains (residues 1–454) and a
large cytosolic C-terminal domain (residues
455–831). The transmembrane domains
implicated in ion transport are depicted in yellow
and the domain responsible for inhibition by
amiloride is depicted in pink (transmembrane
domain IX). The diagram also indicates the
putative binding sites for CHP (calcineurin
homologous protein), ezrin and the NHERFs
(sodium–hydrogen exchanger regulatory factor),
the proton modifier sites (H+ sensor) and the sites
that are phosphorylated by either protein kinase A
(PKA) and serum and glucocorticoid kinase
(SGK). DPP, dipeptidyl peptidase.
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Function
NHE3 mediates the exchange of extracellular Na+ for intracellular
H+ with a stoichiometry of 1:1. Sodium–proton exchange through
NHE3 is therefore electroneutral. The driving force of this cross-
membrane exchange is the large inward gradient of Na+ generated
by the Na+/K+-ATPase. Consequently the exchanger is secondarily
active. NHE3 is capable of functioning in reverse (exchanging
intracellular Na+ for extracellular H+) if the chemical gradients are
inverted (Alexander et al., 2007; Wakabayashi et al., 2003). Studies
where the extracellular concentration of Na+ was varied revealed a
Hill coefficient 1, suggesting a single extracellular Na+-binding
site (Levine et al., 1993). NHE3 preferentially exchanges Na+ for
H+, although extracellular lithium and H+ will compete for the Na+-
binding site at comparatively high concentrations. Kinetic analysis
of cytosolic H+ binding revealed a more complex picture (Levine
et al., 1993). The Hill coefficient with respect to internal H+ is
approximately 2, indicating cooperativity in the activation of NHE3
by H+. Based on this and other observations, the existence of two
intracellular H+-binding sites has been postulated: one is
presumably the substrate or H+-transport site whereas the other is
an allosteric modifier site that dictates the ‘set point’ at which the
exchanger becomes acutely activated. Above the set point Na+/H+
exchange is downregulated, preventing excessive alkalinization of
the cytosol. Mutational analysis suggested that the allosteric
modifier activity depends on two histidine residues in the juxta-
membrane region of the cytosolic C-terminus of the exchanger
(Cha et al., 2003).
Hormonal regulation
Several hormones modulate the activity of NHE3. The best-
described mechanism involves parathyroid hormone (PTH)
(Azarani et al., 1995; Azarani et al., 1996). Engagement of the PTH
receptor raises intracellular cAMP levels thereby activating protein
kinase A (PKA), which phosphorylates NHE3 at serines 552 and
605, a mechanism dependent on both ezrin and the NHERF (see
below). This ultimately leads to inhibition of NHE3 activity
(Collazo et al., 2000). Dopamine also inhibits NHE3 activity.
Engagement of the dopaminergic receptor in the proximal tubule
activates PKA- and protein kinase C (PKC)-dependent pathways,
both of which are thought to be necessary for the endocytosis of
NHE3 and the consequent decrease in its activity (Bacic et al.,
2003; Gomes and Soares-da-Silva, 2004; Hu et al., 2001; Pedrosa
et al., 2004; Wiederkehr et al., 2001).
By contrast, NHE3 activity is increased by angiotensin II
(Dixit et al., 2004; Xu et al., 2006). This occurs through a
redistribution of NHE3 to the plasma membrane; a process that
is dependent on c-Src (Tsuganezawa et al., 1998),
phosphatidylinositol 3-kinase (du Cheyron et al., 2003) and an
increased synthesis of the exchanger (Xu et al., 2006).
Glucocorticoids also increase NHE3 activity. Acutely, a direct
phosphorylation of the cytosolic C-terminus of NHE3 by serum
and glucocorticoid kinase (SGK) at serine 663 causes the
redistribution of NHE3 from endomembranes to the apical
membrane (Wang et al., 2005; Yun, 2003; Yun et al., 2002).
More chronic exposure to glucocorticoid leads to an increased
overall expression of the exchanger (Ambuhl et al., 1999;
Kandasamy and Orlowski, 1996). Insulin increases NHE3
activity by similar means. Chronic exposure to insulin increases
surface expression of NHE3 via SGK-catalyzed phosphorylation
(Fuster et al., 2006). Finally, beta adrenergic stimulation (via
epinephrine or norepinephrine) also activates NHE3 (Hall et al.,
1998).
R. T. Alexander and S. Grinstein
Role in mammalian physiology
NHE3 plays a critical role in salt (re)absorption, in the maintenance
of intravascular volume and in pH homeostasis (Alexander and
Grinstein, 2006; Bobulescu and Moe, 2006). Accordingly, NHE3-
null mice display a decreased blood pressure, diarrhea and an acidic
plasma pH (Schultheis et al., 1998). These combined effects result
in volume contraction, as evinced by the severely elevated plasma
rennin and angiotensin levels found in these animals (Schultheis et
al., 1998). The diarrhea is secondary to an increased osmotic load
in the lumen of the intestine and provides direct evidence for the
important role that NHE3 plays in Na+ absorption. Interestingly,
decreased NHE3 expression caused by inflammatory cytokines
appears to induce diarrhea in inflammatory bowel diseases
(Clayburgh et al., 2006; Sullivan et al., 2008). The importance of
NHE3 to renal Na+ and bicarbonate absorption was similarly
demonstrated. Both microperfusion and micropuncture studies on
NHE3-null mice revealed a dramatic decrease (50%) in proximal
tubular Na+ and bicarbonate absorption (Lorenz et al., 1999; Wang
et al., 1999). If not for a significant reduction in their glomerular
filtration rate and increased distal Na+ absorption, these mice would
not be viable (Lorenz et al., 1999; Schnermann, 1999).
The movement of Na+ across the apical membrane creates a
slight but significant osmotic gradient that is responsible for the
osmotically driven flux of water (approximately 120 lday–1)
(Lorenz et al., 1999). NHE3 should therefore also contribute to the
passive paracellular flux of other ions – such as calcium and
magnesium – from the lumen of the proximal tubule. NHE3 plays
a further role in acid–base homeostasis by indirectly facilitating the
proximal tubular absorption of citrate as well as the luminal
retention of ammonium (Bobulescu and Moe, 2008; Brennan et al.,
1988; Nagami, 1988). Finally, the exchanger has also been
implicated in the absorption of filtered proteins from the proximal
tubular lumen (Gekle et al., 2004), probably through a physical
interaction with megalin (Biemesderfer et al., 1999).
Regulation of the distribution of NHE3 at the apical membrane
Endosomal recycling
NHE3 displays a characteristic subcellular distribution (Fig.2),
which facilitates its acute regulation. It is found not only in the
apical plasma membrane (Kaunisto and Rajaniemi, 2002; Noel et
al., 1996; Pushkin et al., 2000) but also in a sub-apical
endomembrane compartment (Biemesderfer et al., 1997; D’Souza
et al., 1998). Little is known about the identity of this
endomembrane compartment, although NHE3 in this locale is
known to exchange with the plasma membrane population
(Kurashima et al., 1998). The movement of exchangers between
compartments serves as a means of altering their number at the
plasma membrane, in turn, altering apical NHE3 activity.
Carbachol (Li et al., 2004), albumin (Klisic et al., 2003),
glucocorticoids (Bobulescu et al., 2005b) and sodium–glucose co-
transport (Zhao et al., 2004) mediate their effects on NHE3 activity
through this mechanism.
Intracellular NHE3 is known to be active (D’Souza et al., 1998)
and has been proposed to contribute to the acidification of the
endomembrane compartment (through the exchange of luminal Na+
for cytosolic H+). This process may facilitate the degradation and/or
release of cargo having undergone endocytosis through
megalin/cubilin; two scavenging proteins known to co-localize
with NHE3 at the base of microvilli and in endosomes of the
proximal tubule (Biemesderfer et al., 1999; Hryciw et al., 2004).
Finally, there is emerging evidence that NHE3 exists in more than
one type of intracellular compartment. Our cell culture work
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suggests that one population of exchangers is in rapid exchange
with the cell surface, while another intracellular population
undergoes little constitutive recycling (Alexander et al., 2005)
(Fig.2). It is possible that this later population is potentially waiting
to be recruited to the cell surface when increased activity of the
exchanger is required acutely.
Cytoskeletal tethering
Ultimately, the balance between exocytosis and endocytosis
dictates the apical expression level of NHE3. The rate of
endocytosis, in turn, depends on the number of exchangers that are
available for internalization at the membrane. In this regard, it is
important to appreciate that not all the plasmalemmal exchangers
are equally susceptible to endocytosis. Only those that can diffuse
in the membrane to enter clathrin-coated pits can be internalized
whereas those that are immobile cannot. Indeed, a sizable sub-
population of the apical NHE3 appear to be tethered to the
cytoskeleton, which results in restricted motion and the inability to
be engaged by the endocytic machinery. As a result, the
cytoskeleton can regulate NHE3 availability and activity. In
support of this notion, perturbations of actin (either through
pharmacological inhibitors or genetic manipulation of the small
Rho-GTPases) were found to inhibit NHE3 activity (Kurashima et
al., 1999; Szaszi et al., 2000). More recent studies confirmed that
an intact actin cytoskeleton is necessary for optimal NHE3 activity.
Manipulation of microvillar actin architecture through the use of
Clostridium difficile toxin B, inhibited NHE3 activity and
redistributed the apical exchangers to an endomembrane
compartment (Alexander et al., 2005; Hayashi et al., 2004). The
best evidence that the actin cytoskeleton retains NHE3 in the apical
membrane was provided by measuring the lateral mobility of the
exchangers in the plane of the membrane. Determinations of
fluorescence recovery after photobleaching (FRAP) demonstrated
that NHE3 is largely immobile in the apical plasma membrane of
epithelia (Alexander et al., 2005; Cha et al., 2004). The first study
by Cha and colleagues used an NHE3 construct tagged with green
fluorescent protein (GFP) at its extreme cytosolic C-terminus and
found that greater than 50% of the exchangers were immobile in
the plane of the membrane (Cha et al., 2004). These studies were
limited by the fact that fluorescence from GFP-tagged NHE3 in
sub-apical endosomes could not be resolved from the
plasmalemmal exchangers. Furthermore, the attachment of a GFP
moiety to the C-terminus of the exchanger, the domain thought to
be responsible for tethering NHE3 to the cytoskeleton, may have
altered its behavior. Instead of GFP, the second study utilized
NHE3 that was tagged by an extracellular epitope, three tandem
HA motifs (Alexander et al., 2005). By reacting the exofacial
epitopes with antibodies added extracellularly, we were able to
detect exclusively those exchangers located on the apical plasma
membrane. Fab fragments were used for immunolabeling to
preclude cross-linking of the exchangers, which might have altered
their mobility. Using this approach, we found that 70% of apically
expressed NHE3 was immobile. Further investigation concluded
that this immobility was not the result of association of the
exchangers with lipid rafts. Instead, the reduced rate of recovery
after photobleaching was attributed to association with the
cytoskeleton, because the mobile fraction of the exchanger
increased markedly when the actin filaments were perturbed. Taken
together, these results support the concept that NHE3 is localized
to the apical plasma membrane, at least in part, through a physical
retention mechanism mediated by the microvillar actin
cytoskeleton.
Is NHE3 attached to the actin cytoskeleton by NHERF and ezrin?
Because attachment to the actin cytoskeleton contributes to the
apical retention of NHE3, potentially altering its activity,
understanding the nature of this interaction has become a research
priority. Unexpected insights were gained from studies designed to
isolate the factor responsible for the cAMP-mediated inhibition of
NHE3, which led to the purification of the NHERF (Weinman et
al., 1993). Subsequent co-immunoprecipitation experiments
revealed that NHERF and NHE3 interact directly in vivo. A PDZ
domain in the C-terminus of NHERF-1 binds to the cytosolic tail
of NHE3 (Weinman et al., 2003b). As NHE3 lacks a canonical
PDZ-binding domain, the precise binding location is not known,
although the four carboxyl terminal amino acid residues, STHM,
 Recycling 
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Fig. 2. A model depicting the proposed subcellular distribution of NHE3 in
epithelial cells. Note that NHE3 is located in two distinct locations on the
apical membrane: most exchangers are tethered to the actin skeleton on
microvilli whereas a smaller sub-population is found in the intramicrovillar
space. The latter is more likely to internalize and exchange with
endomembrane compartments. Endomembrane exchangers can recycle to
the apical membrane but with complex kinetics that suggest the existence
of fast- and slow-exchanging sub-compartments.
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have been implicated (Weinman et al., 2003b). Concurrently,
NHERF was independently identified in a screen for ezrin-binding
partners and named ezrin-binding protein 50 (EBP50) (Reczek et
al., 1997). A third independent study demonstrated ezrin to bind to
the regulatory subunit II of protein kinase A (PKA RII) (Dransfield
et al., 1997). The fact that NHE3 needs to be associated with
NHERF and ezrin to enable cAMP-mediated inhibition was then
confirmed by reconstituting the system (Weinman et al., 2000b).
These findings led to the generation of the current model of cAMP-
mediated inhibition of NHE3, which postulates that the exchanger
associates with PKA indirectly via NHERF and ezrin (Donowitz et
al., 2005; Minkoff et al., 1999; Weinman et al., 2005; Weinman et
al., 2000a; Weinman et al., 2001). When activated, PKA
phosphorylates NHE3 at serine residues 552 and 605 (Kurashima
et al., 1997; Zhao et al., 1999) mediating, or at least facilitating, the
inhibition of the exchanger (Weinman et al., 2000b).
Identification of a second NHERF isoform, NHE3 kinase A-
regulatory protein (E3KARP/NHERF-2), has provided further
complexity to the proposed model. The second isoform shares some
of the functions described for NHERF-1, as it can similarly mediate
inhibition of NHE3 by cAMP (Lamprecht et al., 1998; Yun et al.,
1998). It also appears to be necessary for the Ca2+-mediated
inhibition of NHE3 activity (Choi et al., 2004; Kim et al., 2002;
Lee-Kwon et al., 2003). A third member of the NHERF family,
NHERF-3/PDZK1, also physically interacts with NHE3 in vitro
and augments cAMP-mediated inhibition (Cinar et al., 2007;
Thomson et al., 2005).
Ezrin not only binds to NHERF and PKA but is also known
to associate with actin via its C-terminal domain (Niggli and
Rossy, 2008). It has therefore been tacitly assumed that the same
protein complex that controls NHE3 phosphorylation also serves
to anchor the exchangers to the cytoskeleton. However, the
hypothesis that NHE3 is attached to the apical actin skeleton
through NHERF and ezrin has never been directly tested and
recent findings call into question the validity of this model. First,
the ezrin knockout mouse does not display any of the phenotypic
features that would be anticipated from altered NHE3 activity
caused by changes in its retention or regulation (Saotome et al.,
2004; Tamura et al., 2005). Second, NHE3 localization studies
in these animals failed to show any redistribution of the
exchangers (Saotome et al., 2004). Of note, the phenotype of the
NHERF-1 knockout animal is also inconsistent with major
relocalization of NHE3. These mice are characterized by renal
phosphate wasting and this phenotype appears also in humans
with NHERF-1 mutations (Karim et al., 2008). Similarly, while
NHE3 lost susceptibility to inhibition by cAMP in NHERF-1-
null mice (Cunningham et al., 2004; Murtazina et al., 2007;
Weinman et al., 2003a), the localization of the exchangers was
not noticeably altered in these animals (Broere et al., 2008;
Shenolikar et al., 2002). Third, recent studies reveal that ezrin
can bind to NHE3 directly (Cha and Donowitz, 2008; Cha et al.,
2006), calling into question the need for NHERF-1 in an
association between the actin cytoskeleton and NHE3. Lastly,
another PDZ adaptor protein, Shank2, appears to alter NHE3
activity at least in part by regulating the cell surface expression
(Han et al., 2006). Therefore, the possibility that it may tether
NHE3 to the actin cytoskeleton must also be considered.
The preceding brief overview of the literature makes it clear that
while the role of ezrin and NHERF isoforms in regulating the
phosphorylation of NHE3 is well established, their participation in
targeting and tethering the exchangers is less clear and requires
additional study.
R. T. Alexander and S. Grinstein
Localization to different plasma membrane domains
Not only are the exchangers segregated into surface and
endomembrane populations but evidence also exists to support the
co-existence of at least two different apical sub-populations of
exchangers. Using a variety of techniques including transmission
electron microscopy, immunofluorescence microscopy and
gradient ultra-centrifugation, Biemesderfer and colleagues have
shown that NHE3 exists in at least two distinct sites within the
apical plasma membrane of the renal proximal tubule
(Biemesderfer et al., 1999). The first is an active population or more
active population that resides along the microvilli of the brush
border and co-immunoprecipitates with dipeptidyl peptidase IV
(Girardi et al., 2001; Girardi et al., 2004). The second is a less active
or possibly inactive population that co-immunoprecipitates with
megalin and is found in the regions between microvilli, i.e. the
inter-microvillar spaces (Biemesderfer et al., 2001). Utilizing
similar techniques, McDonough and colleagues provided evidence
that physiologically relevant stimuli such as a high salt diet or PTH
administration decrease proximal tubular sodium absorption and
concomitantly induce the redistribution of NHE3 from microvilli
to the inter-microvillar space (Yang et al., 2008; Zhang et al., 1999).
Analysis of fluorescence recovery after photobleaching are
consistent with the idea that two separate populations of NHE3 co-
exist on the apical membrane. These studies provided evidence for
a rapidly mobile fraction of exchangers and a second, poorly mobile
fraction (Alexander et al., 2005; Cha et al., 2004). Scanning
electron microscopy revealed that about 70% of the exchangers are
associated with microvilli whereas the remainder are scattered in
the inter-microvillar spaces. Remarkably, the fraction of microvilli-
associated NHE3 is similar to the fraction of immobile exchangers
detected by photobleaching. These findings suggest that the
exchangers on the microvilli are tethered to the cytoskeleton
whereas those in the inter-microvillar space are free to diffuse
(Alexander et al., 2005).
Another means of partitioning populations of NHE3 within the
plasma membrane may involve the association with lipid
microdomains, often called rafts. Using the criteria of detergent
solubility and sedimentation pattern on a sucrose gradient,
Donowitz and coworkers inferred that NHE3 localizes to lipid rafts
(Li et al., 2001). In an epithelial cell culture model, they were able
to show that disruption of lipid rafts inhibited NHE3 activity,
suggesting that the raft-associated population was active
(Murtazina et al., 2006). However, our fluorescence recovery
studies failed to detect changes in NHE3 mobility following
disruption of rafts, implying that partition into lipid microdomains
is not the primary mechanism whereby NHE3 is immobilized and
retained in apical membranes (Alexander et al., 2005). Instead it is
possible that an interaction between NHE3 and membrane lipids
may control the activity of the exchangers. Accordingly, Fuster and
colleagues were able to demonstrate that polyphosphoinositides
alter NHE3 activity, although in their experiments, depletion of
cholesterol failed to alter NHE3 activity (Fuster et al., 2004).
Similarly, we were able to increase NHE3 activity by adding a
cone-shaped lipid, lysophosphatidyl choline, to the lipid bilayer
(Alexander et al., 2007). Jointly, these experiments point to a role
of lipids in the control of NHE3 activity but whether lipids
segregate the exchangers into sub-populations or alter their lateral
mobility is not obvious.
Conclusions
In order to regulate intravascular volume, pH and blood pressure,
second-to-second modulation of the amount of Na+ and water
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absorbed from the renal tubule and the intestine must be achieved.
One of the primary sites of regulation is the apical entry step in the
proximal tubule, a process mediated by NHE3. As discussed above,
acute regulation of the net activity of the exchangers is
accomplished, in part, by altering their number in the functional
domain through redistribution between the plasma membrane and
endomembrane populations. Further regulatory complexity is
conferred by altering the state of activation of individual
exchangers within the plasma membrane. This can be accomplished
through interactions with regulatory proteins, such as megalin, or
by post-translational modifications, notably phosphorylation by
cAMP-dependent kinase. In addition, there are other regulatory
elements, such as the cytoskeleton and selected lipids that in all
likelihood affect both the activity and the distribution of NHE3.
Their mode of action at the molecular level should be the subject
of more detailed future studies.
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